|
|
||||||||
|
FIGURE 6. SUV data obtained for PET analysis of 64Cu-CBTE2A-ReCCMSH(Arg11) (500 ng) in C57 mice implanted with B16/F1 tumors. Shown are SUVs of uptakes in tumor (A), liver (B), and kidney (C). SUVs for tumor (A) are low due to mass of peptide administered compared with that in biodistribution study (16 ng).
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |